Congenital familial non-haemolytic hyperbilirubinaemias are potentiall
y lethal syndromes caused by genetic lesions that reduce or abolish he
patic bilirubin UDP-glucuronosyltransferase activity. Here we describe
genetic defects that occur in the UGT1 gene complex that cause three
non-haemolytic unconjugated hyperbilirubinaemia syndromes. The most se
vere syndrome, termed Crigler-Najjar syndrome type I, is mainly associ
ated with mutations in exons 2 to 5 that affect all UGT1 enzymes and m
any of the mutations result in termination codons and frameshifts. Cri
gler-Najjar type II syndrome which is treatable with phenobarbital the
rapy is associated with less dramatic missense mutations or heterozygo
us expression of mutant and normal alleles. Gilbert's syndrome, the mo
st prevalent (2-19% in population studies) and mildest of the three sy
ndromes is principally caused by a TA insertion at the TATA promoter r
egion upstream of the UGT1A1 exon. Current methods used for the diagno
sis and treatment of these diseases are discussed. (C) 1997 Elsevier S
cience B.V.